Hypertension and nephrology - 2018;22(03)

Content

Journal Special issues Previous issue Next number Archives

Hypertension and nephrology

JUNE 10, 2018

[A Letter to Our Readers]

KÉKES Ede

PDF| ÖSSZEFOGLALÓ Cite COPYRIGHT FEES

HUN

2018;22(03)

Hypertension and nephrology

JUNE 10, 2018

[Remembering Professor István Kiss MD (1952-2018) ]

PDF| ÖSSZEFOGLALÓ Cite COPYRIGHT FEES

HUN

2018;22(03)

Hypertension and nephrology

JUNE 10, 2018

[The Significance and Options of Dietary Treatment in Chronic Renal Disease ]

LEDÓ Nóra, SZIRÁKI Zsófia, TISLÉR András

PDF| ÖSSZEFOGLALÓ Cite COPYRIGHT FEES

HUN

2018;22(03)

Hypertension and nephrology

JUNE 10, 2018

[The Effects of Antihypertensive Therapy by Current Recommendations on Depression and Other Psychometric Parameters: Topline Results ]

KŐRÖSI Beáta, LÁSZLÓ Andrea, BATTA Dóra, LÉNÁRT Lilla, FEKETE Andrea, EÖRSI Dániel, CSEPREKÁL Orsolya, TISLÉR András, NEMCSIK-BENCZE Zsófia, GONDA Xénia, RIHMER Zoltán, NEMCSIK János

PDF| ÖSSZEFOGLALÓ Cite COPYRIGHT FEES

HUN

2018;22(03)

Hypertension and nephrology

JUNE 10, 2018

[ACEI or ARB: a Debate Refueled?]

KÉKES Ede, NAGY Judit

PDF| ÖSSZEFOGLALÓ Cite COPYRIGHT FEES

HUN

2018;22(03)

Hypertension and nephrology

JUNE 10, 2018

[Multifactorial Treatment of Type 2 Diabetes from a Cardiovascular Prevention Perspective ]

SZTANEK Ferenc, PUSKÁS István, DEME Albert, ZÖLD Eszter

PDF| ÖSSZEFOGLALÓ Cite COPYRIGHT FEES

HUN

2018;22(03)

Hypertension and nephrology

JUNE 10, 2018

[Antihypertensive effect of rilmenidine focusing on the Hungarian multicenter trial VERITAS]

FARSANG Csaba, FINTA Ervin

[Summary in the antihypertensive therapy, in addition to the RAS-blockers (ACE-inhibitors or ARBs), calcium antagonists and thizid-like diuretics, other antihypertensive drugs with different mechanisms of actions, such as the imidazoline I1 receptor agonists, are beneficially used. Several international and Hungarian studies showed the results of the effects of these agents. Authors emphasize the effects of the VERITAS study showing that in hypertensive patients the imidazoline I1 receptor agonist, rilmenidine significantly decreased the office blood pressure as well as the blood pressure measured by ambulatory blood pressure monitoring (ABPM). The white-coat reaction and left ventricular hypertrophy (LVH) were also decreased. In a separate study involving hypertensive subjects rilmenidine significantly increased baroreflex sensitivity. This effect may contribute - mainly during daytime - to the antihypertensive effect. Authors summarise the most important actions of rilmenidine, and the selected publications on the results of the Hungarian and international investigations.]

PDF| ÖSSZEFOGLALÓ Cite COPYRIGHT FEES

HUN

2018;22(03)

Hypertension and nephrology

JUNE 10, 2018